These controversial results may be explained by different confounding factors that determine GLP-1 release in patients with T2D including that these patients tended to be older, exhibited increased levels of glucagon and fasting free fatty acids levels as well as differences in assays or in diabetes duration [27]. The gene discussed is GCG; the disease is diabetes mellitus.